Novartis Ag logo

Novartis Ag share price today

(NVS)

Novartis Ag share price is $98.35 & ₹8,375.39 as on 25 Dec 2024, 2.30 'hrs' IST

$98.35

-0.1

(-0.1%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Novartis Ag share price in Dollar and Rupees. Guide to invest in Novartis Ag from India. Also see the sentimental analysis on Indian investors investing in Novartis Ag. Get details on the Indian mutual funds that are investing in Novartis Ag. Get Analyst recommendations and forecasts along with all the Novartis Ag's financials.

Novartis Ag share price movements

  • Today's Low: $97.67
    Today's High: $98.45

    Day's Volatility :0.79%

  • 52 Weeks Low: $92.35
    52 Weeks High: $120.92

    52 Weeks Volatility :23.63%

Novartis Ag Returns

PeriodNovartis AgSector (Health Care)Index (Russel 2000)
3 Months
-15.44%
-10.0%
0.0%
6 Months
-8.05%
-5.7%
0.0%
1 Year
-0.1%
2.8%
0.0%
3 Years
12.37%
-0.4%
-21.1%

Novartis Ag Key Statistics

in dollars & INR

Previous Close
$98.45
Open
$98.21
Today's High
$98.4462
Today's Low
$97.6701
Market Capitalization
$194.1B
Today's Volume
$1.0M
52 Week High
$120.92
52 Week Low
$92.35
Revenue TTM
$49.9B
EBITDA
$21.0B
Earnings Per Share (EPS)
$5.73
PE Ratio
16.95
Dividend Yield
3.85%
Profit Margin
35.25%
Quarterly Earnings Growth YOY
0.85%
Return On Equity TTM
28.79%

How to invest in Novartis Ag from India?

It is very easy for Indian residents to invest directly in Novartis Ag from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Novartis Ag stock in both Indian Rupees (INR) and US Dollars (USD). Search for Novartis Ag or NVS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Novartis Ag or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Novartis Ag shares which would translate to 0.009 fractional shares of Novartis Ag as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Novartis Ag, in just a few clicks!

Returns in Novartis Ag for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Novartis Ag investment value today

Current value as on today

₹1,02,196

Returns

₹2,196

(+2.2%)

Returns from Novartis Ag Stock

₹203 (-0.20%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Novartis Ag

-5.51%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Investment in Novartis Ag from India has reduced in the last 30 days as on Dec 25, 2024. -5.51% less purchase transactions for Novartis Ag in the last 30 days versus the previous period.

-6%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Novartis Ag on INDmoney from India has reduced in the last 30 days as on Dec 25, 2024. -6% less investors are searching Novartis Ag in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Novartis Ag

NameShares HeldChange in Shares% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
2762
0.00
1.61%

Global Institutional Holdings in Novartis Ag

  • Dodge & Cox

    0.61%

  • PRIMECAP Management Company

    0.60%

  • Dimensional Fund Advisors, Inc.

    0.40%

  • Morgan Stanley - Brokerage Accounts

    0.35%

  • Loomis, Sayles & Company LP

    0.29%

  • Bank of America Corp

    0.25%

Analyst Recommendation on Novartis Ag

Buy

    50%Buy

    43%Hold

    6%Sell

Based on 32 Wall street analysts offering stock ratings for Novartis Ag(by analysts ranked 0 to 5 stars)

Based on 32 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
15
17
Hold
14
14
13
Sell
2
2
2

Analyst Forecast on Novartis Ag

What analysts predicted

Upside of 15.94%

Current:

$98.35

Target:

$114.03

Insights on Novartis Ag

  • Price Movement

    In the last 7 days, NVS stock has moved down by -0.7%
  • Increasing Revenue

    Novartis AG has shown consistent growth in revenue over the past four quarters. Starting at $11.77 billion, the revenue increased to $13.17 billion. This represents an average increase of 3.6% per quarter.
  • Decreasing Net Profit

    Novartis AG has experienced a decline in net profit over the last two quarters. The net profit decreased from $3.24 billion to $3.18 billion, showing an average decrease of 1.8% per quarter.
  • NVS vs LLY (1 yr)

    In the last 1 year, Eli Lilly And Company has given 39.6% return, outperforming this stock by 39.9%
  • NVS vs LLY (3 yr)

    In the last 3 years, Eli Lilly And Company has given 191.6% return, outperforming this stock by 178.0%
  • Price to Sales

    Novartis Ag has a Price-to-Sales Ratio of 4.0, meaning investors are willing to pay $4.00 for every $1.00 in sales. In comparison, Eli Lilly And Company has a much higher Price-to-Sales Ratio of 17.6, indicating that investors are willing to pay significantly more for each dollar of sales generated by Eli Lilly.

Novartis Ag Financials in INR & Dollars

FY18Y/Y Change
Revenue
$53.2B
↑ 6.05%
Net Income
$12.6B
↑ 63.72%
Net Profit Margin
23.72%
↑ 8.36%
FY19Y/Y Change
Revenue
$48.7B
↓ 8.44%
Net Income
$7.1B
↓ 43.33%
Net Profit Margin
14.68%
↓ 9.04%
FY20Y/Y Change
Revenue
$49.9B
↑ 2.51%
Net Income
$8.1B
↑ 12.94%
Net Profit Margin
16.18%
↑ 1.5%
FY21Y/Y Change
Revenue
$52.9B
↑ 5.97%
Net Income
$24.0B
↑ 197.58%
Net Profit Margin
45.43%
↑ 29.25%
FY22Y/Y Change
Revenue
$51.8B
↓ 1.98%
Net Income
$7.0B
↓ 71.05%
Net Profit Margin
13.42%
↓ 32.01%
FY23Y/Y Change
Revenue
$46.7B
↓ 9.97%
Net Income
$14.9B
↑ 113.52%
Net Profit Margin
31.83%
↑ 18.41%
Q2 FY23Q/Q Change
Revenue
$13.9B
↑ 5.51%
Net Income
$2.3B
↑ 1.0%
Net Profit Margin
16.62%
↓ 0.74%
Q3 FY23Q/Q Change
Revenue
$12.1B
↓ 13.23%
Net Income
$1.8B
↓ 23.96%
Net Profit Margin
14.56%
↓ 2.06%
Q4 FY23Q/Q Change
Revenue
$11.8B
↓ 2.61%
Net Income
$8.5B
↑ 381.54%
Net Profit Margin
72.01%
↑ 57.45%
Q1 FY24Q/Q Change
Revenue
$11.8B
↑ 0.45%
Net Income
$2.7B
↓ 68.3%
Net Profit Margin
22.72%
↓ 49.29%
Q2 FY24Q/Q Change
Revenue
$12.5B
↑ 5.77%
Net Income
$3.2B
↑ 20.76%
Net Profit Margin
25.94%
↑ 3.22%
Q3 FY24Q/Q Change
Revenue
$13.2B
↑ 5.27%
Net Income
$3.2B
↓ 1.76%
Net Profit Margin
24.21%
↓ 1.73%
FY18Y/Y Change
Profit
$34.8B
↑ 5.46%
FY19Y/Y Change
Profit
$34.3B
↓ 1.46%
FY20Y/Y Change
Profit
$34.8B
↑ 1.53%
FY21Y/Y Change
Profit
$37.0B
↑ 6.42%
FY22Y/Y Change
Profit
$36.3B
↓ 1.8%
FY23Y/Y Change
Profit
$34.2B
↓ 5.93%
Q2 FY23Q/Q Change
Profit
$9.6B
↑ 3.43%
Q3 FY23Q/Q Change
Profit
$9.0B
↓ 6.46%
Q4 FY23Q/Q Change
Profit
$8.8B
↓ 2.46%
Q1 FY24Q/Q Change
Profit
$8.7B
↓ 0.63%
Q2 FY24Q/Q Change
Profit
$9.3B
↑ 6.85%
Q3 FY24Q/Q Change
Profit
$9.9B
↑ 6.92%
FY18Y/Y Change
Operating Cash Flow
$14.3B
↑ 13.08%
Investing Cash Flow
$-5.6B
↑ 79.26%
Financing Cash Flow
$-4.2B
↓ 45.12%
FY19Y/Y Change
Operating Cash Flow
$13.6B
↓ 4.53%
Investing Cash Flow
$-2.2B
↓ 60.19%
Financing Cash Flow
$-13.6B
↑ 221.09%
FY20Y/Y Change
Operating Cash Flow
$13.7B
↑ 0.18%
Investing Cash Flow
$-13.2B
↑ 492.18%
Financing Cash Flow
$-2.2B
↓ 83.8%
FY21Y/Y Change
Operating Cash Flow
$15.1B
↑ 10.41%
Investing Cash Flow
$4.2B
↓ 131.92%
Financing Cash Flow
$-16.3B
↑ 636.59%
FY22Y/Y Change
Operating Cash Flow
$14.2B
↓ 5.54%
Investing Cash Flow
$1.5B
↓ 65.11%
Financing Cash Flow
$-20.6B
↑ 26.43%
FY23Y/Y Change
Operating Cash Flow
$14.5B
↑ 1.56%
Investing Cash Flow
$5.6B
↑ 281.2%
Financing Cash Flow
$-14.3B
↓ 30.56%
Q2 FY23Q/Q Change
Operating Cash Flow
$3.6B
↑ 20.93%
Investing Cash Flow
$-1.1B
↓ 109.91%
Financing Cash Flow
$-3.6B
↓ 60.48%
Q3 FY23Q/Q Change
Operating Cash Flow
$5.4B
↑ 50.39%
Investing Cash Flow
$-2.2B
↑ 110.07%
Financing Cash Flow
$-832.0M
↓ 77.12%
Q4 FY23Q/Q Change
Operating Cash Flow
$2.5B
↓ 52.64%
Investing Cash Flow
$-1.8B
↓ 20.43%
Financing Cash Flow
$-607.0M
↓ 27.04%
Q1 FY24Q/Q Change
Operating Cash Flow
$2.3B
↓ 11.07%
Investing Cash Flow
$-899.0M
↓ 48.92%
Financing Cash Flow
$-5.2B
↑ 750.74%

Novartis Ag Technicals Summary

Sell

Neutral

Buy

Novartis Ag is currently in a neutral trading position according to technical analysis indicators.

Novartis Ag Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Novartis Ag
-4.92%
-8.05%
-0.1%
12.37%
3.23%
Eli Lilly And Company
5.47%
-11.65%
39.53%
186.01%
505.44%
Johnson & Johnson
-6.75%
-1.06%
-6.96%
-14.38%
-0.33%
Merck & Co. Inc.
-1.77%
-24.43%
-7.67%
29.78%
8.6%
Novo Nordisk A/s
-15.16%
-38.25%
-13.61%
58.94%
204.53%
Abbvie Inc
0.75%
4.23%
15.37%
32.72%
99.99%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Novartis Ag
16.95
16.95
2.89
7.6
0.29
0.11
0.04
21.67
Eli Lilly And Company
85.44
85.44
0.72
13.14
0.65
0.14
0.01
15.83
Johnson & Johnson
23.88
23.88
0.87
9.96
0.21
0.08
0.03
29.14
Merck & Co. Inc.
20.51
20.51
0.07
7.74
0.28
0.11
0.03
17.58
Novo Nordisk A/s
28.52
28.52
1.27
22.83
0.89
0.21
0.02
27.07
Abbvie Inc
61.39
61.39
0.42
10.94
0.56
0.08
0.04
3.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Novartis Ag
Buy
$194.1B
3.23%
16.95
35.25%
Eli Lilly And Company
Buy
$716.1B
505.44%
85.44
20.48%
Johnson & Johnson
Buy
$347.8B
-0.33%
23.88
16.74%
Merck & Co. Inc.
Buy
$248.0B
8.6%
20.51
19.23%
Novo Nordisk A/s
Buy
$363.6B
204.53%
28.52
35.01%
Abbvie Inc
Buy
$310.3B
99.99%
61.39
9.22%

Novartis Ag Dividend announcements

  • Novartis Ag Dividends March, 2024

    In the quarter ending March,2024. Novartis Ag has declared dividend of $3.78

    Read More

About Novartis Ag

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Organization
Novartis Ag
Employees
76057
CEO
Dr. Vasant Narasimhan M.D.
Industry
Health Technology

Management People of Novartis Ag

NameTitle
Dr. Vasant Narasimhan M.D.
Chief Executive Officer
Mr. Harry Kirsch
Chief Financial Officer
Mr. Victor Bulto
President of US
Dr. Patrick Horber M.D.
President of International
Dr. Steffen Lang Ph.D.
President of Operations
Paul Penepent
Head of Group Financial Reporting and Accounting
Ms. Sloan Simpson
Global Head of Investor Relations
Dr. Klaus Moosmayer Ph.D.
Chief Ethics, Risk & Compliance Officer
Ms. Karen L. Hale
Chief Legal Officer
Dr. Robert Kowalski Pharm.D.
Chief People & Organization Officer

Important FAQs about investing in Novartis Ag from India :

What is Novartis Ag share price today?

Novartis Ag share price today stands at $98.35, Open: $97.72 ; Previous Close: $98.45 ; High: $98.45 ; Low: $97.67 ; 52 Week High: $120.92 ; 52 Week Low: $92.35. The stock opens at $97.72, after a previous close of $98.45. The stock reached a daily high of $98.45 and a low of $97.67, with a 52-week high of $120.92 and a 52-week low of $92.35.

Can Indians buy Novartis Ag shares?

Yes, Indians can invest in the Novartis Ag (NVS) from India.

With INDmoney, you can buy Novartis Ag at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Novartis Ag at zero transaction cost.

How can I buy Novartis Ag shares from India?

It is very easy to buy Novartis Ag from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Novartis Ag be purchased?

Yes, you can buy fractional shares of Novartis Ag with INDmoney app.

What are the documents required to start investing in Novartis Ag stocks?

To start investing in Novartis Ag, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Novartis Ag

Today’s highest price of Novartis Ag (NVS) is $98.45.

Today’s lowest price of Novartis Ag (NVS) is $97.67.

What is today's market capitalisation of Novartis Ag

Today's market capitalisation of Novartis Ag NVS is 194.1B

What is the 52 Week High and Low Range of Novartis Ag

  • 52 Week High

    $120.92

  • 52 Week Low

    $92.35

What are the historical returns of Novartis Ag?

  • 1 Month Returns

    -4.92%

  • 3 Months Returns

    -8.05%

  • 1 Year Returns

    -0.1%

  • 5 Years Returns

    3.23%

Who is the Chief Executive Officer (CEO) of Novartis Ag

Dr. Vasant Narasimhan M.D. is the current Chief Executive Officer (CEO) of Novartis Ag.